UK lifts drug rebate rate as pharma industry decries ‘fundamentally broken’ market
Under one of two policy tools that the U.K. uses to control drug costs, the British government has proposed to lift the rebate rate for newer medicines under the statutory scheme from 15.5% currently to 32.2% in the second half of 2025.
Under one of two policy tools that the U.K. uses to control drug costs, the British government has proposed to lift the rebate rate for newer medicines under the statutory scheme from 15.5% currently to 32.2% in the second half of 2025.
